Our reports
- About us
- Our work
- In the news
- Monthly news round-up
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- August 2008
- July 2008
- June 2008
- May 2008
- Monthly news round-up
- Resources
- Events
- Contact us
- Support us
- What's new
- Search
-
Melzer D, Hogarth S, Liddell K, Ling T, Sanderson S, Zimmern R. Genetic tests for common diseases: new insights, old concerns. British Medical Journal. 2008 Mar 15;336(7644):590-3
-
Hall A, Liddell K. Beyond Bristol and Alder Hey: The Future Regulation of Human Tissue. Medical Law Review. 2005;Summer:170-223
-
Liddell K, Wallace S. Emerging Regulatory Issues for Human Stem Cell Medicine. Genomics, Society and Policy. 2005;1(1):54-73
-
Menon D, Liddell K, Zimmern R. The Human Tissue Bill and the Mental Capacity Bill. British Medical Journal. 2004;328(7455):1510-1
-
Liddell K. Purposive interpretation and the march of genetic technology. Case comment on the R v HFEA 2 W.L.R. (cell nuclear transfer case). Cambridge Law Journal. 2003;62(3):563-6